Farther Finance Advisors LLC Grows Position in Itron, Inc. $ITRI

Farther Finance Advisors LLC boosted its stake in Itron, Inc. (NASDAQ:ITRI) by 52.5% in the second quarter, HoldingsChannel reports. The institutional investor owned 1,240 shares of the scientific and technical instruments company’s stock after buying an additional 427 shares during the quarter. Farther Finance Advisors LLC’s holdings in Itron were worth $163,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of ITRI. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in Itron by 129.7% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 732,274 shares of the scientific and technical instruments company’s stock valued at $76,713,000 after buying an additional 413,487 shares during the last quarter. Amundi raised its position in Itron by 18.4% in the 1st quarter. Amundi now owns 929,407 shares of the scientific and technical instruments company’s stock valued at $97,313,000 after buying an additional 144,361 shares during the last quarter. GAMMA Investing LLC raised its position in Itron by 10,278.1% in the 1st quarter. GAMMA Investing LLC now owns 122,150 shares of the scientific and technical instruments company’s stock valued at $12,796,000 after buying an additional 120,973 shares during the last quarter. MetLife Investment Management LLC raised its position in Itron by 347.2% in the 1st quarter. MetLife Investment Management LLC now owns 121,043 shares of the scientific and technical instruments company’s stock valued at $12,680,000 after buying an additional 93,977 shares during the last quarter. Finally, Trexquant Investment LP raised its position in Itron by 122.5% in the 1st quarter. Trexquant Investment LP now owns 168,535 shares of the scientific and technical instruments company’s stock valued at $17,656,000 after buying an additional 92,773 shares during the last quarter. 96.19% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Itron

In other news, SVP John F. Marcolini sold 565 shares of the stock in a transaction on Monday, August 25th. The stock was sold at an average price of $125.31, for a total transaction of $70,800.15. Following the completion of the transaction, the senior vice president owned 14,396 shares in the company, valued at approximately $1,803,962.76. This represents a 3.78% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Christopher E. Ware sold 351 shares of the stock in a transaction on Monday, August 25th. The stock was sold at an average price of $125.31, for a total value of $43,983.81. Following the transaction, the senior vice president owned 19,117 shares of the company’s stock, valued at $2,395,551.27. The trade was a 1.80% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 3,037 shares of company stock worth $380,566 in the last three months. Corporate insiders own 1.45% of the company’s stock.

Itron Stock Up 1.0%

ITRI stock opened at $123.59 on Friday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.75 and a current ratio of 2.04. The company has a market capitalization of $5.65 billion, a price-to-earnings ratio of 21.13, a PEG ratio of 0.67 and a beta of 1.48. Itron, Inc. has a fifty-two week low of $90.11 and a fifty-two week high of $140.04. The stock has a fifty day moving average of $124.24 and a 200-day moving average of $119.00.

Itron (NASDAQ:ITRI) last posted its quarterly earnings results on Thursday, July 31st. The scientific and technical instruments company reported $1.62 earnings per share for the quarter, topping the consensus estimate of $1.33 by $0.29. The company had revenue of $606.76 million during the quarter, compared to the consensus estimate of $610.36 million. Itron had a return on equity of 19.69% and a net margin of 11.05%.The firm’s quarterly revenue was down .4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.21 EPS. Itron has set its FY 2025 guidance at 6.000-6.200 EPS. Q3 2025 guidance at 1.450-1.550 EPS. As a group, equities research analysts predict that Itron, Inc. will post 5.33 earnings per share for the current year.

Wall Street Analyst Weigh In

ITRI has been the subject of a number of analyst reports. Stephens set a $130.00 price target on Itron in a research report on Monday, August 4th. TD Cowen raised their target price on Itron from $139.00 to $145.00 and gave the company a “buy” rating in a research report on Friday, June 20th. Roth Capital raised their target price on Itron from $130.00 to $150.00 and gave the company a “buy” rating in a research report on Tuesday, July 22nd. Guggenheim reaffirmed a “buy” rating and set a $155.00 target price (up from $133.00) on shares of Itron in a research report on Monday, July 14th. Finally, Wall Street Zen lowered Itron from a “buy” rating to a “hold” rating in a research report on Saturday, September 20th. Nine equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $137.10.

Itron Profile

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.